Terumo (STU:TUO) Long-Term Debt: €1,131 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TUO Terumo Corp STU:TUO
82 GF Score
Price €14.26
GF Value €16.88
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Terumo Long-Term Debt?

Terumo STU:TUO +0.46% 82 Long-Term Debt is €1,131 Mil as of Jun. 2026. GuruFocus rates STU:TUO with a GF Score™ of 82/100 and a GF Value™ of €16.88 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Terumo's Long-Term Debt for the quarter that ended in Jun. 2026 was €1,131 Mil.

Terumo's quarterly Long-Term Debt declined from Dec. 2025 (€547 Mil) to Mar. 2026 (€545 Mil) but then increased from Mar. 2026 (€545 Mil) to Jun. 2026 (€1,131 Mil).

Terumo's annual Long-Term Debt increased from Mar. 2024 (€460 Mil) to Mar. 2025 (€992 Mil) but then declined from Mar. 2025 (€992 Mil) to Mar. 2026 (€545 Mil).

Terumo  (STU:TUO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Terumo Long-Term Debt Related Terms

Terumo Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Terumo's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Long-Term Debt Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,721.97 1,542.27 460.42 991.90 544.62

Terumo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 599.30 575.55 547.17 544.62 1,131.20
STU:TUO
82GF Score
Terumo Corp STU:TUO
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €1,131 Mil mean?
Terumo (STU:TUO) has a Long-Term Debt of €1,131 Mil as of Jun. 2026.
Is Terumo's Long-Term Debt too high?
Terumo's current Long-Term Debt is €1,131 Mil. Overall, Terumo has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Long-Term Debt compare to ISRG and BDX?
Terumo's Long-Term Debt of €1,131 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Terumo's current Long-Term Debt is €1,131 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (STU:TUO) is currently considered Modestly Undervalued. The stock's GF Value™ is €16.88, compared to a current price of €14.26 — trading 15.6% below its estimated fair value. The current Long-Term Debt is €1,131 Mil. Terumo's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Terumo (STU:TUO), the current Long-Term Debt is €1,131 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (STU:TUO) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of €14.26 is trading 15.6% below its estimated GF Value™ of €16.88. GuruFocus considers Terumo to be Modestly Undervalued.

Key valuation signals for STU:TUO:

  • Long-Term Debt: €1,131 Mil
  • GF Value™: €16.88 vs. price of €14.26 (15.6% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the STU:TUO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
82GF Score

Get the complete analysis for STU:TUO

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.26
Price
€16.88
GF Value